Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.

New research suggests that cancer patients referred for outpatient palliative care may not be receiving adequate treatment for pain.

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

(HealthDay News) — Both dual use of traditional and electronic cigarettes and exclusive cigarette use are associated with higher toxicant exposure than exclusive e-cigarette use, according to a study ...

(HealthDay News) — Smoking, eating, vaping, and dabbing are the most common routes of marijuana use, according to research published in the April 10 issue of the U.S. Centers for Disease Control and ...

(HealthDay News) — Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to a study published in the February issue of the Clinical ...

Based on 13 cross-sectional studies, the researchers found that higher dietary inflammatory index scores were associated with significantly higher odds of chronic kidney disease (odds ratio, 1.36) and ...

Obesity in itself is not a contraindication for radical prostatectomy, but it remains a risk factor for poor overall survival.

Significant cognitive decline, increased depressive symptoms, and reduced self-care reported among those with heart failure. (HealthDay News) — Patients with heart failure experience worsening ...

Although recommended, many patients with metastatic clear cell RCC still don’t receive immune checkpoint inhibitor-based combinations as first-line treatment.

Treatment with dapagliflozin reduced the risk of death or worsening heart failure by 28% compared with standard of care. Dapagliflozin reduced the risk of death or worsening heart failure (HF) in ...